Optimizing echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.

Optimizing echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations. by Lepak A, Castanheira M, Diekema D, Pfaller M and Andes D published in Antimicrob. Agents Chemother. 2012; 56 (11): 5875-5882